CHILDRENS HOSP RES FOUNDATION has a total of 26 patent applications. Its first patent ever was published in 1983. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are S I S SHULOV INST FOR SCIENCE, RORER BIOTECHNOLOGY and ALPHA 1 BIOMEDICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 6 | |
#2 | United States | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 2 | |
#5 | Israel | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Ireland | 1 | |
#10 | India | 1 | |
#11 | Japan | 1 | |
#12 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Harding Paul A | 11 |
#2 | Brigstock David A | 8 |
#3 | Clark Leland C Jr | 5 |
#4 | Brigstock David R | 3 |
#5 | Bourne Nigel | 2 |
#6 | Clark Jr Leland C | 2 |
#7 | Stanberry Lawrence R | 2 |
#8 | Shaw Robert F | 1 |
#9 | Stanberry Lawrence Raymond | 1 |
#10 | Ackerman Jerome L | 1 |
Publication | Filing date | Title |
---|---|---|
WO0021522A1 | Use of metformin to counteract weight gain associated with valproate and other psychotropic medications | |
AU3891199A | Method of hsv prophylaxis | |
WO9951094A1 | Intravaginal use of triclosan | |
US5876730A | Heparin-binding growth factor (HBGF) polypeptides | |
US5536753A | Stable perfluorocarbon and oil emulsions | |
US4775522A | NMR compositions for indirectly detecting a dissolved gas in an animal |